Pharmacy

Your Article Summary

See Latest Articles

Pharmacogenetics and the potential for the individualization of antiretroviral therapy
Current Opinion in Infectious Diseases, 01/22/08

Phillips EJ et al. - Differences in HIV acquisition and progression as well as antiretroviral efficacy and toxicity will continue to provide the basis for research to define the genetic basis of such diversity. Despite the plethora of research in this area, numerous barriers exist to the successful operationalization of genetic testing to the clinic. HLA-B5701 screening to prevent abacavir hypersensitivity is currently the most relevant to clinical practice and highlights that the promise of cost-effective testing can be facilitated by robust laboratory methodology and quality assurance programs that can be applied to diverse treatment settings

Today in Antimicrobials...keeping you current

Receive free subspecialty "5-minute updates" via email

Diagnosis and treatment of fungal infections in allogeneic stem cell and solid organ transplant recipients
Expert Opinion in Pharmacotherapy, 12/14/09

Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: Results of a prospective randomized trial
Surgery Today, 12/14/09

Relevance of CD38 Expression on CD8 T Cells to Evaluate Antiretroviral Therapy Response in HIV-1-infected Youths
Scandinavian Journal of Immunology, 12/14/09

 See all of Antimicrobials